Rasmussen`s Encephalitis
... trials have usually been performed in individual patients and there are no good data on the optimum combination, dosing, or duration of immune treatments. ...
... trials have usually been performed in individual patients and there are no good data on the optimum combination, dosing, or duration of immune treatments. ...
before movements ceased. The (Swedo SE et al. Sydenham`s dance
... Lyme disease. Penicillin V (60% of patients), amoxicillin (25%), tetracycline (10%), or doxycycline (5%), had been given orally for 10 to 30 days. None of the patients had carditis, arthritis, or neurologic complications attributable to Lyme disease. A recurrence of erythema migrans was reported in ...
... Lyme disease. Penicillin V (60% of patients), amoxicillin (25%), tetracycline (10%), or doxycycline (5%), had been given orally for 10 to 30 days. None of the patients had carditis, arthritis, or neurologic complications attributable to Lyme disease. A recurrence of erythema migrans was reported in ...
project to develop image-guided localized drug delivery technologies
... effects of treatments for cancer and cardiovascular disease Eindhoven, the Netherlands - Royal Philips Electronics today announced that it is leading a major new European project to develop drug delivery technologies that could significantly impact the treatment of cancer and cardiovascular disease. ...
... effects of treatments for cancer and cardiovascular disease Eindhoven, the Netherlands - Royal Philips Electronics today announced that it is leading a major new European project to develop drug delivery technologies that could significantly impact the treatment of cancer and cardiovascular disease. ...
SLE Patient-Partner Experience
... • The activity that we had last Saturday was great and also exciting • The patients presented in remission. Because of this, I now truly believe that the disease is not only treatable, but in the future, may also be curable with the advent of biogenic medications. • competent physicians, like Thomas ...
... • The activity that we had last Saturday was great and also exciting • The patients presented in remission. Because of this, I now truly believe that the disease is not only treatable, but in the future, may also be curable with the advent of biogenic medications. • competent physicians, like Thomas ...
AB146PSI-AOAPO_KumariP_30092016
... infiltrated immune cells significantly modify its protective function. Various immune mediators secreted from resident cells of synovial tissue and infiltrated inflammatory cells eventually result into joint destruction. Besides, insufficient knowledge behind disease progression, unavailability of d ...
... infiltrated immune cells significantly modify its protective function. Various immune mediators secreted from resident cells of synovial tissue and infiltrated inflammatory cells eventually result into joint destruction. Besides, insufficient knowledge behind disease progression, unavailability of d ...
Study Impact Approval Form Guidelines
... Principal Investigator (P.I.): The person responsible for the conduct of the clinical research at Sunnybrook. Hospital Resources: Human and material resources including those which are currently paid by and/or accessed through the hospital (e.g. diagnostic services, pharmacy, staff time, increased l ...
... Principal Investigator (P.I.): The person responsible for the conduct of the clinical research at Sunnybrook. Hospital Resources: Human and material resources including those which are currently paid by and/or accessed through the hospital (e.g. diagnostic services, pharmacy, staff time, increased l ...
Case presentations - Southern Neurology
... Patients with 2 or more signal abnormalities > 3 mm size in periventricular region were 12 times more likely to develop clinically definite MS within 2 years. ...
... Patients with 2 or more signal abnormalities > 3 mm size in periventricular region were 12 times more likely to develop clinically definite MS within 2 years. ...
Guidelines for Infectious Disease Consultation 1. In order to help us
... All patients with Staph aureus in their blood (MRSA or MSSA) ...
... All patients with Staph aureus in their blood (MRSA or MSSA) ...
Press Release TB status Delhi F
... implications for child survival, economic productivity and family welfare. There is also the fear of stigma and rejection from family members and society. It is estimated that annually more than 100,000 women with TB are abandoned by their families. More than 300,000 children are forced to leave sch ...
... implications for child survival, economic productivity and family welfare. There is also the fear of stigma and rejection from family members and society. It is estimated that annually more than 100,000 women with TB are abandoned by their families. More than 300,000 children are forced to leave sch ...
Helping Patients Make Comfortable Treatment Decisions
... • Longer disease duration and worse disease perception tend to increase a person’s risk tolerance (Tur et al., 2012) – which means that risk tolerance is a moving target. • People are more likely to be influenced by their JC antibody status before starting treatment with Tysabri than after they have ...
... • Longer disease duration and worse disease perception tend to increase a person’s risk tolerance (Tur et al., 2012) – which means that risk tolerance is a moving target. • People are more likely to be influenced by their JC antibody status before starting treatment with Tysabri than after they have ...
BP602 T. PHARMACOLOGY-III (Theory)
... BP602 T. PHARMACOLOGY-III (Theory) 45 Hours Scope: This subject is intended to impart the fundamental knowledge on various aspects (classification, mechanism of action, therapeutic effects, clinical uses, side effects and contraindications) of drugs acting on respiratory and gastrointestinal system, ...
... BP602 T. PHARMACOLOGY-III (Theory) 45 Hours Scope: This subject is intended to impart the fundamental knowledge on various aspects (classification, mechanism of action, therapeutic effects, clinical uses, side effects and contraindications) of drugs acting on respiratory and gastrointestinal system, ...
Eulji University Hospital
... With potent induction regimens, drug-free holidays may be a realistic goal to mitigate the potential risks associated with the long-term use of immunosuppressive drugs. In the BEST study, a randomized trial comparing four different treatment strategies in early RA, 56% of 120 patients who started tr ...
... With potent induction regimens, drug-free holidays may be a realistic goal to mitigate the potential risks associated with the long-term use of immunosuppressive drugs. In the BEST study, a randomized trial comparing four different treatment strategies in early RA, 56% of 120 patients who started tr ...
STUDI PENGGUNAAN ANTIBIOTIKA PADA PASIEN TUMOR OTAK
... Purpose. This study was designed to examine the use of antibiotic including its type, dose, route, duration of administration, and frequency in patients with brain tumors of which trepanation-excision of the tumor performed. Result. This study was conducted retrospectively from period of January to ...
... Purpose. This study was designed to examine the use of antibiotic including its type, dose, route, duration of administration, and frequency in patients with brain tumors of which trepanation-excision of the tumor performed. Result. This study was conducted retrospectively from period of January to ...
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)
... Conventional therapies for multiple sclerosis using immunosuppressants, monoclonal antibodies etc. effectively reduce inflammation, but do little in terms of repair to the damaged central nervous system [6]. Treatment with beta-interferons were considered a major advance in the treatment of this dis ...
... Conventional therapies for multiple sclerosis using immunosuppressants, monoclonal antibodies etc. effectively reduce inflammation, but do little in terms of repair to the damaged central nervous system [6]. Treatment with beta-interferons were considered a major advance in the treatment of this dis ...
clinical - Royal College of Physicians of Edinburgh
... number of new inflammatory lesions and the rate of relapse in patients with recent onset multiple sclerosis, and the possible value of adopting a very aggressive therapeutic approach at the beginning of the disease process when the extent of the diseases is not obvious to the patient and the level o ...
... number of new inflammatory lesions and the rate of relapse in patients with recent onset multiple sclerosis, and the possible value of adopting a very aggressive therapeutic approach at the beginning of the disease process when the extent of the diseases is not obvious to the patient and the level o ...
Laboratory Analysis
... • Gas chrom. to test concentration of alcohol in blood – tested first • Urine – barbiturates or other depressants – immunoassay • Immunoassay = presumptive screening tool for specific chemical – done 1st • Then, confirmatory test – GC-MS – get quantitative results ...
... • Gas chrom. to test concentration of alcohol in blood – tested first • Urine – barbiturates or other depressants – immunoassay • Immunoassay = presumptive screening tool for specific chemical – done 1st • Then, confirmatory test – GC-MS – get quantitative results ...
(safinamide) New Drug Application (NDA)
... and reduce costs (including staff costs), (2) the market for drugs to treat CNS diseases and pain conditions, (3) Newron’s anticipated future revenues, capital expenditures and financial resources, and (4) assumptions underlying any such statements. In some cases these statements and assumptions can ...
... and reduce costs (including staff costs), (2) the market for drugs to treat CNS diseases and pain conditions, (3) Newron’s anticipated future revenues, capital expenditures and financial resources, and (4) assumptions underlying any such statements. In some cases these statements and assumptions can ...
Oxford BioMedica Announces Update on TroVax® Development
... Oxford, UK – 10 October 2012: Oxford BioMedica (“Oxford BioMedica” or “the Company”) (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that it plans to close the Phase II study in the United States (US) to assess the activity of TroVax® (MVA-5T4) in patients with progress ...
... Oxford, UK – 10 October 2012: Oxford BioMedica (“Oxford BioMedica” or “the Company”) (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that it plans to close the Phase II study in the United States (US) to assess the activity of TroVax® (MVA-5T4) in patients with progress ...
Immunophysics and Immunoengineering: Computational
... Age-related macular degeneration (AMD) is a leading cause of vision loss in the US. Like many other autoimmune diseases, AMD has been a challenge to treat despite years of rigorous research. Dr. Dimitrios Morikis, Professor of Bioengineering at the University of California, Riverside, uses computati ...
... Age-related macular degeneration (AMD) is a leading cause of vision loss in the US. Like many other autoimmune diseases, AMD has been a challenge to treat despite years of rigorous research. Dr. Dimitrios Morikis, Professor of Bioengineering at the University of California, Riverside, uses computati ...
Replagal, INN-agalsidase alfa
... Replagal has been examined in two clinical studies, involving a total of 40 male patients. Replagal was compared with a placebo (a dummy treatment) and its effect on pain was measured in one study and its effect on clearing Gb3 from the left ventricle (heart muscle) was studied in the other. A furth ...
... Replagal has been examined in two clinical studies, involving a total of 40 male patients. Replagal was compared with a placebo (a dummy treatment) and its effect on pain was measured in one study and its effect on clearing Gb3 from the left ventricle (heart muscle) was studied in the other. A furth ...
